Corporate Tech Investors

Intellia Therapeutics

Intellia Therapeutics is a corporate entity that partners with firms that align with the company's business objectives.

Venture Investor Overview

Contact Information

Background Information

Overview

Intellia is a pioneer in the development of CRISPR/Cas9 genome editing and is rapidly moving experimental therapies towards the clinic. Our company's unique strengths include our modular lipid nanoparticle delivery system and our determined focus on product development.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

2/2/2022

Transaction History

Our records indicate that Intellia Therapeutics invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

John Leonard

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Intellia Therapeutics has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Intellect Capital Ventures | Intelligent Beauty

Share this article

About Our Database of Corporate Tech Investors

This corporate tech investment data comes via a partnership with VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary